The Uptake of Telemedicine in Obstetric Care During the Early Acute Phase of the Coronavirus 2019 Pandemic


Introduction

The coronavirus disease 2019 (COVID-19) pandemic forced rapid adaptation in health care delivery. Medical interventions were postponed and telemedicine was quickly adopted to limit face-to-face interactions and minimize exposure risk.1,2 However, most obstetric care cannot be delayed, posing unique challenges to pregnancy management. We examined associations of patient characteristics, timing of core obstetric services, and select birth outcomes with telemedicine utilization during the initial phase of the COVID-19 pandemic.

Methods

We conducted a retrospective cohort study of patients receiving prenatal care (PNC) at two academic institutions in two different states during the early COVID-19 pandemic era (patients with last menstrual periods December 4, 2019–March 9, 2020). Institutional Review Board approval was obtained at both institutions. PNC telemedicine use, patient characteristics, obstetric services, and birth outcomes were ascertained from electronic medical record data. Health care utilization was examined by timing and number of PNC encounters, ultrasounds, and glucose challenge testing (GCT). Comparisons were made within institution using chi-square and Student’s t tests as appropriate.

Results

A total of 2,006 and 1,246 births occurred at institutions A and B, respectively, and 82.0% and 48.5% of patients had ≥1 telemedicine PNC encounter, respectively (Table 1). Telemedicine utilization was associated with significant patient-level differences at each institution, but in opposing directions. Telemedicine uptake at Institution A was highest among non-Hispanic White or Asian and commercially insured, whereas at Institution B, uptake was highest among non-Hispanic Black or Hispanic and publicly insured. At both institutions, patients with gestational diabetes and COVID-19 infection were more likely to use telemedicine. Telemedicine users initiated PNC earlier, had more total PNC visits, were more likely to have a first trimester ultrasound, and underwent earlier GCT (Table 1). There were no significant differences in cesarean or stillbirth based on telemedicine use at either institution.

Table 1. Use of Telemedicine During Prenatal Care in the Early COVID Era and Characteristics of Patients at Two Academic Perinatal Centers

  INSTITUTION A INSTITUTION B
NO TELEMEDICINE (n = 362) TELEMEDICINE (n = 1,644) p NO TELEMEDICINE (n = 642) TELEMEDICINE (n = 604) p
Total 18.0% 82.0%   51.5% 48.5%  
Age (years)     0.0002     0.88
 <25 25.5% 74.5%   52.2% 47.8%  
 25–29 20.7% 79.3%   50.4% 49.6%  
 30–34 15.5% 84.5%   52.8% 47.2%  
 35+ 15.1% 84.9%   50.3% 49.7%  
Race and ethnicity     <0.001     <0.0001
 Asian 13.4% 86.6%   49.2% 50.8%  
 Hispanic 24.3% 75.7%   46.2% 53.9%  
 Non-Hispanic White 11.4% 88.6%   57.7% 42.3%  
 Non-Hispanic Black 22.7% 77.3%   37.3% 62.7%  
 None of the above 21.7% 78.3%   71.4% 28.6%  
Marital status     <0.001     0.16
 Not married 23.4% 76.6%   48.9% 51.1%  
 Married or living as married 13.0% 87.0%   53.0% 47.0%  
Insurance status     <0.001     0.0008
 Public or other insurance 24.7% 75.3%   45.6% 54.4%  
 Commercial insurance 13.0% 87.0%   55.4% 44.7%  
BMI     0.0074     0.003
 <30 kg/m2 15.8% 84.2%   52.9% 47.1%  
 ≥30 kg/m2 20.8% 79.2%   43.4% 56.6%  
Smoking during pregnancy     0.0008     0.53
 No 17.0% 83.0%   51.8% 48.2%  
 Yes 32.8% 67.2%   48.2% 51.8%  
Parity     0.21     0.23
 Nulliparous 16.3% 83.7%   53.3% 46.7%  
 Parous 18.5% 81.5%   49.9% 50.1%  
Hypertension            
 Pre-existing HTN 19.6% 80.4% 0.67 41.5% 58.5% 0.01
 HDP (any) 20.7% 79.3% 0.099 48.5% 51.5% 0.27
Diabetes            
 Pre-existing diabetes 17.4% 82.6% 0.92 36.8% 63.2% 0.10
 Gestational diabetes 10.2% 89.8% 0.009 22.6% 77.4% <0.0001
COVID-19 during pregnancy     0.77     0.02
 No 18.1% 81.9%   52.2% 47.8%  
 Yes 17.0% 83.0%   34.1% 65.9%  
Antenatal care visitsa            
 Total no. of PNC visitsb 6.0 ± 3.9 10.5 ± 3.0 <0.001 9.5 ± 3.8 11.0 ± 3.7 <0.0001
 Total no. of in-person PNC visitsb 6.0 ± 3.9 7.8 ± 2.7 <0.001 9.5 ± 3.8 10.0 ± 3.7 0.19
 GA (days) at 1st in person PNC visitb 140.9 ± 83.9 79.4 ± 43.1 <0.001 99.3 ± 58.5 82.9 ± 43.1 <0.001
Antenatal testinga            
 No ultrasound 8.6% 1.2% <0.001 1.6% 0.5% 0.09
 No anatomy scan 8.8% 1.3% <0.001 5.1% 1.3% <0.0001
 1st ultrasound in 1st trimester 31.8% 46.8% <0.0001 57.4% 73.7% <0.0001
 Total no. of ultrasoundsb 2.2 ± 1.4 2.7 ± 1.6 <0.001 5.3 ± 3.9 6.4 ± 4.2 <0.001
Timing of antenatal testinga            
 GA days at first ultrasoundb 129.4 ± 63.2 105.0 ± 49.0 <0.001 100.5 ± 60.0 76.8 ± 38.8 <0.001
 GA days at 1st anatomy scanb 159.9 ± 37.1 144.2 ± 19.4 <0.001 145.0 ± 29.2 136.9 ± 15.7 <0.001
 GA days at 1st GCTb 195.5 ± 31.6 189.2 ± 30.3 0.002 176.5 ± 44.6 162.5 ± 53.3 <0.0005
Perinatal outcomesa            
 Cesarean birth 29.6% 28.5% 0.69 31.0% 32.0% 0.71
 Stillbirth 0.8% 0.4% 0.27 0.8% 0.5% 0.73

Discussion

With no baseline telemedicine use at either institution, there was rapid adoption of telemedicine for PNC during the early phase of the COVID-19 pandemic. There were notable patient-level and hospital-level differences in telemedicine adoption, consistent with varied implementation in prior studies.3,4 Although patients with gestational diabetes were more likely to use telemedicine, and telemedicine users accessed obstetric services earlier in gestation, this did not translate to observed differences in delivery mode or stillbirth.

Telemedicine may improve access to health care by reducing logistic and economic barriers.5 We found that telemedicine users had at least as many in-person visits as nonusers, suggesting that telemedicine augmented rather than replaced in-person PNC. In a bundled obstetric care payment system, this may be viewed as a value-added service; however, further research should assess whether supplemental telemedicine improves outcomes. Our study highlights successful efforts to maintain adequate PNC provision amidst the acute challenges of the early pandemic.

Conclusions

Obstetric telemedicine was rapidly adopted amidst a public health crisis, but implementation varied across institutions. It remains unclear whether telemedicine promotes or ameliorates disparities in access to obstetric care given the varied findings between institutions. Further research is needed to guide clinicians, administrators, and policymakers as they consider the role of telemedicine during PNC outside the context of a crisis.

Authors’ Contributions

Writing—original draft preparation (equal) and writing—review and editing (lead) by K.M.M. Data curation (equal), methodology, and formal analysis (equal) by L.S.L. Conceptualization (supporting), data curation (equal), and writing—review and editing (supporting) by H.H.B. Data curation (equal), formal analysis, and writing—review and editing (supporting) by R.F.L. Writing—review and editing (supporting) by M.S., J.G., S.C.H., and K.D. Conceptualization (lead), data curation (equal), methodology, formal analysis (equal), writing—original draft preparation (equal), and writing—review and editing (supporting) by J.C.

Disclosure Statement

No competing financial interests exist.

Funding Information

H.H.B., M.S., S.C.H., and J.C. received financial support from Highmark Blue Cross Blue Shield Delaware’s donor-advised fund, BluePrints for the Community, and from Independence Blue Cross from December 1, 2020 to November 30, 2021.

REFERENCES

  • 1. Demeke HB, Pao LZ, Clark H, et al. Telehealth practice among health centers during the COVID-19 pandemic—United States, July 11–17, 2020. MMWR Morb Mortal Wkly Rep 2020;69(50):1902–1905; doi: 10.15585/mmwr.mm6950a4. Crossref, MedlineGoogle Scholar
  • 2. Ukoha EP, Davis K, Yinger M, et al. Ensuring equitable implementation of telemedicine in perinatal care. Obstet Gynecol 2021;137(3):487–492; doi: 10.1097/AOG.0000000000004276. Crossref, MedlineGoogle Scholar
  • 3. Limaye MA, Lantigua-Martinez M, Trostle ME, et al. Differential uptake of telehealth for prenatal care in a large New York city academic obstetrical practice during the COVID-19 pandemic. Am J Perinatol 2021;38(3):304–306; doi: 10.1055/s-0040-1721510. Crossref, MedlineGoogle Scholar
  • 4. Chunara R, Zhao Y, Chen J, et al. Telemedicine and healthcare disparities: A cohort study in a large healthcare system in New York City during COVID-19. J Am Med Inform Assoc 2021;28(1):33–41; doi: 10.1093/jamia/ocaa217. Crossref, MedlineGoogle Scholar
  • 5. Almuslim H, AlDossary S. Models of incorporating telehealth into obstetric care during the COVID-19 pandemic, its benefits and barriers: A scoping review. Telemed J E Health 2022;28(1):24–38; doi: 10.1089/tmj.2020.0553. LinkGoogle Scholar





Source link